Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Triple Negative Breast Neoplasms 9Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 6Melanoma 4Head and Neck Neoplasms 4Ovarian Neoplasms 3Carcinoma, Renal Cell 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Urinary Bladder Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms 1Mesothelioma, Malignant 1Lung Neoplasms 1Hypersensitivity 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1Carcinoma, Hepatocellular 1Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

Ultrasonography 2tislelizumab 1Mammography 1Immune Checkpoint Inhibitors 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypersensitivity × Immune Checkpoint Inhibitors × Breast × Clear all
NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Shandong University

Unknown
200 enrolled
Breast

Hypersensitivity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡